Pro-apoptotic protein Bax and anti-apoptotic protein Bcl-2 expression in streptozotocin model of Alzheimer's disease

HealthMED

Volumn 3, Issue 4, 2009, Pages 520-528

  Kundurovic, Z ^a   Hasanagic, S ^a   Bilalovic, N ^b   Gavrankapetanovic, F ^b   Alicelebic, S ^b  

^a umarski Fakultet Univerziteta U Sarajevu   (Bosnia and Herzegovina)

^b KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

Author keywords

Anti Bax and anti Bcl2 polyclonal antibodies; Experimental model of sporadic alzheimer's disease; Immunohistochemistry; Rat; STZ

Indexed keywords

EID: 77949472400     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Banks W.A.(2004) The source of cerebral insulin. Eur.J.Pharmacol. 490, 5-12.
2. Plata-Salaman C.R. (1991)Insulin in the cerebrospinal fluid. Neurosci.Biobehav.Rev. 15, 243-258
3. Schechter R.and Abboud M.(2001) Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures. Brain Res.Dev. BrainRes. 127, 41-49.
4. Schechter R.,Whitmire J.,Holtzclaw L.,George M.,Harlow R.and Devaskar S.U.(1992) Developmental regulation of insulin in the mammalian central nervous system. BrainRes. 582, 27-37.
5. Hoyer S., Nitsch R.and Oesterreich K. (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross sectional comparison against advanced late-onset and incipient early-onset cases. J.NeuralTransm.Park.Dis.Dement.Sect. 3, 1-14.
6. Hoyer S. (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur.J.Pharmacol. 490, 115-17.
7. Zhao W.Q., Chen H.,Quon M.J. and Alkon D.L.(2004) Insulin and the insulin receptorin experimental models of learning and memory. Eur.J.Pharmacol. 490, 71-81.
8. Park C.R., Seeley R.J., Craft S.and Woods S.C.(2000) Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol. Behav. 68, 509-514.
9. F rolichL., Blum-Degen D., Bernstein H.G. et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J.Neural Transm. 105, 423-438.
10. Hoyer S.and Frolich L.(2006) Brain function and insulin signal transduction in sporadic Alzheimer's disease, in Research Progress in Alzheimer's Disease and Dementia (Sun M. K.,ed.), Chapter11. Nova Science, NewYork.
11. Luchsinger JA, Tang MX, Shea S, Mayeux R. (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology.63(7):1187-92.
12. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M.(2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 63(10):1902-7.
13. Xu W, Qiu C, Winblad B, Fratiglioni L. (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes. 56(1):211-6.
14. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein (2007) J Neurochem. 101, 757-770
15. Ankarcrona M, Winblad B. (2005) Biomarkers for apoptosis in Alzheimer's disease. Int J Geriatr Psychiatry. 20(2):101-5.
16. Helguera P , Pelsman A, Pigino G, Wolvetang E,Head E, Busciglio J (2005) ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons. The Journal of Neuroscience, 25(9):2295-2303
17. Hengartner MO.(2000) The biochemistry of apoptosis. Nature,407:770-6.
18. Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis.Nat. Med. 3, 614- 620
19. Reed, J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387, 773-776
20. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM (1998) Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4:1421-1424
21. Pietrowski PK, Wierzbicka K, Smiatek M (2001) Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants, Folia Neuropathol. 39:147- 154.
22. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL (1999) Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6:347-363
23. Barber AJ, Lieth E, Khim SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 102:783-791
24. Mathew CE, Berdanier CD (1998) Noninsulin-dependent diabetes mellitus as a mitochondrial genomic disease. Proc Soc Exper Biol Med 219:97-108
25. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM (1998) Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4:1421-1424
26. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K.(2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 45(8):2760-6.
27. Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka,Y., Nomura,Y., Smith, M.A., Whitehouse, P.J., Taniguchi, T. (1998). Alteration of proteins regulating apoptosis,Bcl-2,Bcl-x, Bax,Bak,Bad, ICH-1and CPP32 inAlzheimer's disease. BrainRes.780, 260-269
28. MacGibbon,G.A., Lawlor,P.A., Sirimanne,S.E.,Wa lton,M.R.,Connor, B.,Young,D., Williams,C., Gluckman, P., Faull, R.L.M., Hughes,P., Dragunow,M., (1997) Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. BrainRes.750. 223-234
29. Engidawork, E., Gulesserian, T., Yoo, B.C., Cairns, N., Lubec, G., (2001) Alteration of caspases and apoptosis-related proteins in brains of Patients with Alzheimer's disease. Biochem.Biophys. Res.Commun. 281,84-93.
30. Su, J. H., Deng, G., Cotman, C. W. (1997) Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol. 56,
31. Zhao, M., Su, J., Head, E., Cotman, C. W. (2003) Accumulation of caspase cleaved amyloid precursor protein represents anearly neurodegenerative event in aging and in Alzheimer's disease. Neurobiol. Dis.14, 391-401.
32. Pompl, P. N., Yemul, S., Xiang, Z., Ho, L., Harutunian, V., Purohit, D., Mohs, R., Pasinetti, G. M., (2003) Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.Arch.Neurol.60,360- 376.
33. Rohn, T. T., Head, E., Nessen, W. H., Cotman, C. E., Cribbs, D. H. (2001) Activation of caspase-8 in the Alzheimer's disease brain.Neurobiol. Dis.8,1006-1016.
34. Rohn, T. T., Rissman, R. A., Davis, M. C., Kim, Y. E., Cotman, C. W., Head, E. (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol.Dis.11,341-354.
35. Woodhouse A, et al. (2006) No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis. 22:323-33
36. Putcha GV, Deshmukh M, Johnson Jr EM (1999) Bax translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, Bcl-2, and caspases. J Neurosci 19: 7476-7485
37. Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci USA 98: 2837-2842.
38. Lustbader, J.W. et al. ( 2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 304:448-452.
39. Gross A, McDonnell JM, Korsmeyer SJ. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-911.
40. Wang X.(2001)The expanding role of mitochondria in apoptosis.Genes Dev 2922-33
41. Rissman RA, Poon WW, Blurton-Jones M , et al. (2004) Caspase cleavage of tau is an early event in Alzheimer disease tangle pathology J.Clin Invest, 114: 121-130
42. Canu, N. et al. 1998. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18:7061-7074
43. Johnson, G.V., Jope, R.S., Binder, L.I. (1989). Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163:1505-1511
44. Wang S, Rosengren LE, Franlund M, Hamberger A, Haglid KG.(1999) Bcl-2 expression regulates cell sensitivity to S100beta-mediated apoptosis. Brain Res Mol Brain Res. 18;70(1):167-76.
45. Dickson DW (2004) Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J. Clin. Invest. 114:23-27
46. Stadelmann, C., Bruck, W., Bancher, C., Jellinger, K., and Lassmann, H. (1998). Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J. Neuropathol. Exp. Neurol. 57:456-464
47. Su, J.H., Zhao, M., Anderson, A.J., Srinivasan, A., and Cotman, C.W. (2001). Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 898:350-357